bw 737c89 has been researched along with eedq in 1 studies
Studies (bw 737c89) | Trials (bw 737c89) | Recent Studies (post-2010) (bw 737c89) | Studies (eedq) | Trials (eedq) | Recent Studies (post-2010) (eedq) |
---|---|---|---|---|---|
7 | 0 | 0 | 329 | 0 | 9 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Riddall, DR | 1 |
1 other study(ies) available for bw 737c89 and eedq
Article | Year |
---|---|
A comparison of the selectivities of SCH 23390 with BW737C89 for D1, D2 and 5-HT2 binding sites both in vitro and in vivo.
Topics: Adrenergic alpha-Antagonists; Animals; Benzazepines; Binding Sites; Brain; Dopamine Antagonists; Dose-Response Relationship, Drug; Injections, Subcutaneous; Isoquinolines; Male; Quinolines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Serotonin; Tetrahydroisoquinolines | 1992 |